Fidelity International’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Fidelity International's ALNY Position: Q3 2026 in Review
Fidelity International reduced its Alnylam Pharmaceuticals (ALNY) stake by 91% in Q3 2026, selling an estimated $21.2M and leaving 8,668 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #783.
Fidelity International first reported a position in ALNY in Q3 2022 and has held it in 17 quarters since. The position peaked at $61.8M in Q3 2025. 730 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Fidelity International held 8,668 shares of Alnylam Pharmaceuticals worth $2.14M as of Q3 2026.
- Fidelity International sold 83,370 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $21.2M.
- Alnylam Pharmaceuticals made up ﹤0.01% of Fidelity International's portfolio in Q3 2026, its #783 holding.
- Fidelity International first reported a position in Alnylam Pharmaceuticals in Q3 2022 and has held it in 17 quarters since.
- Fidelity International's Alnylam Pharmaceuticals position peaked at $61.8M in Q3 2025.
- 730 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Fidelity International's 13F filing for Q3 2026, filed 10 Nov 2026.